|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2005-4-12
|
|
pubmed:abstractText |
Primary effusion lymphoma (PEL) represents a peculiar lymphoma infected with human herpesvirus 8 (HHV-8) and occurs predominantly in human immunodeficiency virus (HIV)-infected patients. The aim of the present study was to evaluate the immunologic and virological parameters, including HHV-8 viremia, of 5 HIV-infected patients with PEL whose disease was diagnosed and treated at our institute.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1022-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15824995-Adult,
pubmed-meshheading:15824995-Anti-HIV Agents,
pubmed-meshheading:15824995-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15824995-CD4 Lymphocyte Count,
pubmed-meshheading:15824995-Disease Progression,
pubmed-meshheading:15824995-Female,
pubmed-meshheading:15824995-Gene Expression Regulation, Viral,
pubmed-meshheading:15824995-HIV Infections,
pubmed-meshheading:15824995-Herpesvirus 8, Human,
pubmed-meshheading:15824995-Humans,
pubmed-meshheading:15824995-Lymphoma, Non-Hodgkin,
pubmed-meshheading:15824995-Male,
pubmed-meshheading:15824995-Viral Load,
pubmed-meshheading:15824995-Viral Proteins,
pubmed-meshheading:15824995-Viremia
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.
|
|
pubmed:affiliation |
Division of Medical Oncology A, National Cancer Institute, Aviano, Italy. csimonelli@cro.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
